Social Survey Research Information Co., Ltd.

Jul 5th, 2018  -  Social Survey Research Information Co., Ltd.

Top 15 manufactures for Sales Rep visit in China

Pfizer ranked first, followed by Astra Zeneca and Byer

Pfizer has the highest sales rep visitation rate in China followed by AstraZeneca and Bayer:

PatientsMap 2018 CN asks doctors about sales rep visitations of 69 pharmaceutical companies in the past month. Below table shows the top 15 pharmaceutical companies with the highest sales rep visitation rates. Top 7 companies are major global pharmaceutical companies, and Chinese local companies ranked 8th, 10th, 12th and 15th. No Japanese companies ranked within the top 15th, with the highest being Eisai at 21st (8.1%).

PatientsMap2018 CN- Top 15 Sales Rep visit ranking (n=10,285)

Overall rankCompany NameN=%
2Astra Zeneca3,22931.4%
8CHIA TAI TIANQING (CTTQ) Pharmaceutical1,67516.3%
10Yangtze River Pharmaceutical (Group)1,61815.7%
12Qilu Pharmaceutical1,41313.7%
13Eli Lily1,39813.6%
14Novo Nordisk1,24412.1%
15Jiangsu Hengrui Medicine Distribution1,17611.4%
Focusing only on Japanese companies, "Eisai" ranked 21st overall and its sales rep visit visitation rate was 8%. As below, Takeda ranked 27th, Daiichi Sankyo 30th, Otsuka 32nd in order

PatientsMap 2018CN Sales Rep visit – Japanese company (n=10,285)

Overall rankCompany NameN=
30Daiichi Sankyo4804.7%
37Sumitomo Dainippon Pharma3403.3%

SSRI and M3 started selling PatientsMap 2018CN since June 4, 2018.

The Japanese version of PatientsMap is a database that investigates the number of patients with about 400 diseases through cooperation of over 20,000 doctors every year.


PatientsMap has also released US and UK versions so far, the Chinese version is the 4th country as the PatientsMap series



“PatientsMap 2018CN” – Outline-

The respondents of this study was randomly selected per specialty/department from members of, administrated by Chinese affliate of and is a portal site for healthcare professionals with 2,130,000 online members,.


Studied medical conditions:           357 conditions

Sample source:                              M3 Global Research online physician panel

Sample department:                      All departments in hospitals and clinics

Methodology:                                  Online survey

Sample size:                                   Total of 10,285 physicians

Fieldwork schedule:                        3rd January 2018~6th March 2018

Contents of the survey:                  Medical conditions that they treat

Number of patients they see per medical condition

Number of patients in which they administer medicine to

Medical conditions in which they wish for new products

Sales rep visitation status


This service is provided jointly by Social Survey Research Co., Ltd., M3, Inc. and M3 Global Research.


■Contact Information   Social Survey Research Information Co., Ltd

Contact: Chiharu Sakai



■ Social Survey Research Information Co., Ltd

Established         April 1982

Capital                 27 million yen

Executive            President & CEO Takashi Makita

Staff                     110 staff members

Address               NMF Shinjuku EAST Bldg.

10-5 Tomihisacho, Shinjuku-ku, Tokyo 162-0067



Osaka Office        Tetsutani Bldg. 502

2-2-2 Tokui-cho, Chuo-ku, Osaka540-0025



Affiliate companies PD Research Co., Ltd.



URL                  /index.html

  • M3, Inc.

Established          September 2000

Capital                 15 billion and 31 million yen

Director               Representative Director Itaru Tanimura

Subsidiaries staff               3,556 staff members (as of end of March 2016)

Address               Akasaka Intercity 10th floor

1-11-44 Akasaka

Minato-ku, Tokyo 107-0052




Established: April 2013

Capital: 2 million CNY

General manager: Tian Liping

Number of staffs: 210

Address: Beijing Red Manor International Bonded Innovation Park E-1,

Baijialou 1, Chaoyang North Road, Chaoyang District,

Beijing 100024